'Huge therapeutic potential': University of Sask. researchers make progress on stroke treament
A drug typically used to treat schizophrenia is showing positive signs during early stages of research, bringing down stroke-related swelling in the brain.
The research is being conducted by the researchers from the University of Saskatchewan, Columbia University, and the University of Oxford with help from the Canadian Light Source involves a drug called trifluoperazine (TFP).
TFP is already approved for human use and researchers believe it has the potential to stop swelling in the brain that occurs after a stroke or cerebral injury.
According to a release from the CLS, TFP acts on “doughnut-shaped” water channel proteins called aquaporins, which are in brain cells.
During a stroke, the blood supply to the brain is restricted and prevents cells from receiving enough oxygen, which leads to swelling in the brain as oxygen-starved cells cannot do their usual job of maintaining a balance of fluid, nutrients, and electrolytes.
“Water rushes from the outside through these doughnut-shaped proteins, into the cells that then swell. The build-up of pressure damages the fragile brain tissue, disturbing the flow of electrical signals from the brain to the body,” Dr. Mootaz Salman, Research Scientist in the Department of Physiology, Anatomy, and Genetics at the University of Oxford and the corresponding author on this studysaid in a release.
“Edema, which is swelling due to water or other body fluid accumulation, is the hallmark of stroke and plays a major role in stroke-associated morbidity and mortality.”
The idea is that TFP stops all of this from happening by preventing a signal that would normally cause more aquaporin channels to rise to the surface of brain cells.
“Our novel approach offers new hope for patients with central nervous system injuries and strokes and has a huge therapeutic potential,” Dr. Salman said in the release.
“These findings suggest it could be a good candidate for early phase of human clinical application at a low treatment cost in the near future.”
Dr. Patrice Lindsay, Director of Health Systems Change at the Heart and Stroke Foundation said that any research done to further the medical communities knowledge on strokes is crucial.
“Any new research that’s coming out that shows promise at reducing the impact of stroke, reducing the damage that could be caused, is very exciting, and things we will be watching very closely. We need more research like this,” Dr. Lindsay said.
Dr. Lindsay said international partnerships are important for the field, combining expertise and resources goes a long way to further the study as a community.
“We’re encouraging those international partnerships. Rather than duplicating each other’s work, to work together and leverage, and you can get so much further ahead so much faster. These partnerships are so exciting and a great example for others to follow,” Dr. Lindsay said.
As TFP is already approved for human use, Dr. Lindsay said the process to vigorously test the drug will be a bit quicker, meaning it could potentially be helping patients sooner than if it was a brand new drug.
“We will continue to monitor very closely as this research evolves. When the evidence is substantial enough we can try to quickly move it into practice so it can help as many patients as possible,” Dr. Lindsay told CTV.
CTVNews.ca Top Stories
How more than 100 women realized they may have dated, been deceived by the same man
An Ontario man is being accused of changing his name, profession and life story multiple times to potentially more than 100 women online before leaving some out thousands of dollars.

Mother charged with sexual abuse of toddler in Edmonton area after FBI tip
A Strathcona County toddler has been rescued from suspected sexual exploitation, and the child's mother has been charged, police said.
LeBron James becomes NBA's all-time scoring leader, surpassing Kareem Abdul-Jabbar
LeBron James is the NBA's new career scoring leader. With a stepback jump shot with 10.9 seconds left in the third quarter against the Oklahoma City Thunder on Tuesday night, James pushed his career total to 38,388 points on Tuesday night and broke the record that Kareem Abdul-Jabbar held for nearly four decades.
Biden in State of Union urges U.S. Congress: 'Finish the job'
U.S. President Joe Biden exhorted Congress Tuesday night to work with him to 'finish the job' of rebuilding the economy and uniting the nation as he delivered a State of the Union address aimed at reassuring a country beset by pessimism and fraught political divisions.
Fears grow for untold numbers buried by Turkiye earthquake as deaths pass 7,700
Rescuers raced against time early Wednesday to pull survivors from the rubble before they succumbed to cold weather two days after an earthquake tore through southern Turkiye and war-ravaged northern Syria. The death toll climbed above 7,700 and was expected to rise further.
Canadian military plane heads home after two surveillance flights over Haiti
A Canadian Armed Forces surveillance plane was heading home on Tuesday after two intelligence-collecting flights over Haiti.
On list of 50 'most Instagrammable' places, only 1 is in Canada
A new ranking by global travel site Big 7 Travel has revealed the most Instagrammable places for people to visit in 2023, but only one Canadian location, Banff, is among them.
Spy balloon part of a broader Chinese military surveillance operation, U.S. intel sources tell CNN
U.S. intelligence officials believe that the recently recovered Chinese spy balloon is part of an extensive surveillance program run by the Chinese military, according to multiple American officials familiar with the intelligence.
From $55 to $130: Which Canadians plan to spend the most this Valentine's Day?
As Valentine's Day approaches, many Canadians are preparing to celebrate by taking their loved ones to dinner and buying them gifts, but how much are we spending on this day coast to coast?